SNTI Senti Biosciences Inc.

  1. Stocks
  2. Healthcare
  3. NASDAQ: SNTI

Price (delayed)

$0.338

Market cap

$10.53M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.72

Enterprise value

$22.86M

?
Relative Growth: Rel. Growth: 18
Relative Strength: Rel. Strength: 2
Relative Valuation: Rel. Valuation: 1
Relative Profitability: Rel. Profitability: 28
Highlights
SNTI's EPS has surged by 81% year-on-year and by 8% since the previous quarter
SNTI's gross profit is up by 45% since the previous quarter
The debt has decreased by 35% YoY but it has increased by 6% from the previous quarter
Senti Biosciences's equity has shrunk by 114% YoY
The quick ratio has dropped by 80% year-on-year and by 44% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of SNTI

SNTI stock price

How has the Senti Biosciences stock price performed over time
Intraday
7.1%
1 week
8.58%
1 month
-13.02%
1 year
-75.68%
YTD
-67.5%
QTD
-69.27%

Financial performance

How have Senti Biosciences's revenue and profit performed over time
Revenue
$55,000
Gross profit
$55,000
Operating income
-$61.57M
Net income
-$49.56M
Gross margin
100%
Net margin
-90,116.4%
SNTI's gross profit is up by 45% since the previous quarter
The revenue has grown by 45% from the previous quarter
The net margin has increased by 34% from the previous quarter
Senti Biosciences's operating margin has increased by 33% QoQ

Price vs fundamentals

How does SNTI's price correlate with its fundamentals

Growth

What is Senti Biosciences's growth rate over time

Valuation

What is Senti Biosciences stock price valuation
P/E
N/A
P/B
N/A
P/S
191.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
415.71
SNTI's EPS has surged by 81% year-on-year and by 8% since the previous quarter
Senti Biosciences's equity has shrunk by 114% YoY
The revenue has grown by 45% from the previous quarter

Efficiency

How efficient is Senti Biosciences business performance
The ROA has contracted by 49% YoY and by 16% from the previous quarter
The ROIC is down by 41% year-on-year and by 17% since the previous quarter
SNTI's return on sales is up by 34% since the previous quarter

Dividends

What is SNTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SNTI.

Financial health

How did Senti Biosciences financials performed over time
The company's total assets is 9% lower than its total liabilities
The quick ratio has dropped by 80% year-on-year and by 44% since the previous quarter
SNTI's current ratio has dropped by 75% year-on-year and by 20% since the previous quarter
SNTI's debt to equity has dropped by 180% since the previous quarter
Senti Biosciences's equity has shrunk by 114% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.